Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles

Drug Delivery

Volumn 22, Issue 2, 2015, Pages 206-213

  Jiang, Shougang ^a   Gong, Xianfeng ^a,b   Zhao, Xiuhua ^a   Zu, Yuangang ^a  

^a NORTHEAST FORESTRY UNIVERSITY   (China)

^b HEILONGJIANG UNIVERSITY   (China)

Author keywords

Antitumor activities; Docetaxel; Folate; Human serum albumin; Nanoparticles

Indexed keywords

DOCETAXEL; FOLIC ACID; HUMAN SERUM ALBUMIN; NANOPARTICLE; ALB PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; DRUG CARRIER; SERUM ALBUMIN; TAXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; COVALENT BOND; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DOSAGE FORM COMPARISON; DRUG RELEASE; DRUG SOLUBILITY; DRUG TARGETING; FEMALE; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; IN VIVO STUDY; LIGHT SCATTERING; MALE; MORPHOLOGY; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE CHARGE; SURFACE PROPERTY; TUMOR VOLUME; TUMOR XENOGRAFT; X RAY DIFFRACTION; ZETA POTENTIAL; ANIMAL; CARCINOMA, HEPATOCELLULAR; CELL SURVIVAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRUG FORMULATION; LIVER NEOPLASMS, EXPERIMENTAL; METABOLISM; OUTBRED STRAIN; PATHOLOGY; RANDOMIZATION; SARCOMA; SOLUBILITY; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE; ULTRASTRUCTURE;

ANIMALS; ANIMALS, OUTBRED STRAINS; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SURVIVAL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; FOLIC ACID; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; NANOPARTICLES; PARTICLE SIZE; RANDOM ALLOCATION; SARCOMA; SERUM ALBUMIN; SOLUBILITY; SURFACE PROPERTIES; TAXOIDS;

EID: 84921650610     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2013.879964     Document Type: Article

References (35)

1. Cho JK, Hong JM, Han T, et al. (2013). Injectable and biodegradable poly(organophosphazene) hydrogel as a delivery system of docetaxel for cancer treatment. J Drug Target 6:564-73.
2. Conte C, Ungaro F, Maglio G, et al. (2013). Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer. J Control Release 1:40-52.
3. Fauzee NJ, Wang YL, Dong Z, et al. (2012). Novel hydrophilic taxane analogues inhibit growth of cancer cells. Asian Pac J Cancer Prev 2:563-7.
4. Fu Q, Sun J, Zhang W, et al. (2009). Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery. Recent Pat Anticancer Drug Discov 3:262-72.
5. Gan CW, Chien S, Feng SS. (2010). Nanomedicine: enhancement of chemotherapeutical efficacy of docetaxel by using a biodegradable nanoparticle formulation. Curr Pharm Des 21:2308-20.
6. Hawkins MJ, Soon-Shiong P, Desai N. (2008). Protein nanoparticles as drug carriers in clinical medicine. Adv Drug Deliv Rev 8:876-85.
7. Henni-Silhadi W, Deyme M, Boissonnade MM, et al. (2007). Enhancement of the solubility and efficacy of poorly water-soluble drugs by hydrophobically-modified polysaccharide derivatives. Pharm Res 12:2317-26.
8. Jiang S, Zhang Y, Zu Y, et al. (2010). Antitumor activities of extracts and compounds from water decoctions of Taxas cuspidata. Am J Chin Med 6:1107-14.
9. Jiang S, Zu Y, Fu Y, et al. (2008). Activation of the mitochondria-driven pathway of apoptosis in human PC-3 prostate cancer cells by a novel hydrophilic paclitaxel derivative, 7-xylosyl-10-deacetylpaclitaxel. Int J Oncol 1:103-11.
10. Kratz F. (2008). Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release 3:171-83.
11. Langer K, Balthasar S, Vogel V, et al. (2003). Optimization of the preparation process for human serum (HSA) nanoparticles. Int J Pharm 1-2:169-80.
12. Lejon S, Frick IM, Björck L, et al. (2004). Crystal structure and biological implications of bacterial albumin binding module in complex with human serumalbumin. J Biol Chem 41:42924-8.
13. Li X, Zhang J, Wang DK, et al. (2012). Preparation and in vitro properties of folate receptor targeting docetaxel-loaded amphiphilic copolymer-modified liposomes. Yao Xue Xue Bao 9:1219-26.
14. Lin W, Coombes AG, Davies MC, et al. (1993). Preparation of sub-100 nm human serum albuminnanospheres using a pH-coacerbation method. J Drug Target 3:237-43.
15. Low PS, Kularatne SA. (2009). Folate-targeted therapeutic and imaging agents and imaging agents for cancer. Curr Opin Chem Biol 3:256-62.
16. Manjappa AS, Goel PN, Vekataraju MP, et al. (2013). Is an alternative drug delivery system needed for docetaxel? The role of controlling epimerization in formulations and beyond. Pharm Res 10:2675-93.
17. Manoocheheri S, Darvishi B, Kamalinia G, et al. (2013). Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel. Daru 1:58.
18. Mi Y, Liu Y, Feng SS. (2011). Formulation of Docetaxel by folic acid-conjugated D-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy. Biomaterials 16:4058-66.
19. Onishi K, Tsukiyama I, Katoh M, et al. (2013). Preparation of dealcholized onetaxotere®, docetaxel injection formulation and its pharmacokinetics in rats. Gan To Kagaku Ryoho 7:891-6.
20. Pradhan R, Poudel BK, Ramasamy T, et al. (2013). Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physico-chemical characterization and cytotoxicity studies. J Nanosci Nanotechnol 8:5948-56.
21. Ram BG, Uday BK. (2006). Nanoparticle technology for drug delivery. New York, USA: Taylor & Francis Group Inc. 85-6.
22. Ray A, Larson N, Pike DB, et al. (2011). Comparison of active and passive targeting of docetaxel for prostate cancer therapy by HPMA copolymer-RGDfK conjugates. Mol Pharm 4:1090-9.
23. Tan Q, Liu X, Fu X, et al. (2012). Current development in nanoformulations of docetaxel. Expert Opin Drug Deliv 8:975-90.
24. Tao W, Zeng X, Liu T, et al. (2013). Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy. Acta Biomater 11:8910-20.
25. Torrecilla D, Lozano MV, Lallana E, et al. (2013). Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules. Eur J Pharm Biopharm 3:330-7.
26. Wang D, Huang J, Wang X, et al. (2013a). The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel. Biomaterials 31:7662-73.
27. Wang EC, Sinnott R, Werner ME, et al. (2013b). Differential cell responses to nanoparticle docetaxel and small molecule docetaxel at a sub-therapeutic dose range. Nanomedicine. [Epub ahead of print]. doi:10.1016/j.nano.2013.07.012.
28. Wang J, Liu W, Tu Q, et al. (2011). Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery. Biomacromolecules 1:228-34.
29. Weber C, Coester C, Kreuter J, et al. (2000). Desolvation process and surface characterization of protein nanoparticles. Int J Pharm 1:91-102.
30. Yang D, Van S, Shu Y, et al. (2012). Synthesis, characterization, and in vivo efficacy evaluation of PGG-docetaxel conjugate for potential cancer chemotherapy. Int J Nanomedicine 7:581-9.
31. Yared JA, Tkaczuk KH. (2012). Update on taxane development: new analogs and new formulations. Drug Des Dev Ther 6:371-84.
32. Zhao D, Zhao X, Zu Y, et al. (2010). Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles. Int J Nanomedicine 5:669-77.
33. Zhao J, Mi Y, Feng SS. (2013). Targeted co-delivery of docetaxel and siPlk1 by herceptin-conjugated vitamin E TPGS based immunomicelles. Biomaterials 13:3411-21.
34. Zhao P, Astruc D. (2012). Docetaxel nanotechnology in anticancer therapy. Chem Med Chem 6:952-72.
35. Zeng X, Tao W, Mei L, et al. (2013). Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer. Biomaterials 25:6058-67.